Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
49 studies found for:    " January 30, 2008":" February 29, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" January 30, 2008":" February 29, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Safety of and Immune Response to an Adenoviral HIV-1 Vaccine in Healthy Adults
Condition: HIV Infections
Intervention: Biological: Ad26.ENVA.01 HIV-1 vaccine
2 Completed A Phase I Pharmacokinetics and Safety Study of Two Dapivirine Intravaginal Gels
Condition: HIV Infections
Interventions: Drug: Dapivirine Gel 4750, 0.05%, 2.5g;   Drug: Dapivirine Gel 4789, 0.05%, 2.5g;   Drug: HEC-based Placebo Gel
3 Completed Naïve HIV POC Monotherapy Trial
Condition: HIV Infections
Interventions: Drug: RDEA806 400 mg;   Drug: Placebo;   Drug: RDEA806 1000 mg;   Drug: RDEA806 600 mg;   Drug: RDEA806 800 mg
4 Completed Experimental Design of Couple Counseling and Testing in Antenatal Clinics in Dar es Salaam, Tanzania
Condition: HIV Infections
Interventions: Behavioral: Couples VCT;   Behavioral: Individual VCT
5 Active, not recruiting A Rollover Study for Subjects Who Completed Participation in the VRX496-USA-05-002 Trial
Condition: HIV Infections
Intervention: Genetic: VRX496-transduced autologous CD4 T cells
6 Completed ONCE - Only Nocturnal Combination Evaluation of Antiretroviral-Experienced HIV 1 Infected Subjects Switching to Atripla
Condition: HIV Infections
Intervention: Drug: Atripla (ATR) consisting of EFV 600 mg/FTC 200 mg/TDF 300 mg
7 Completed Evaluation of the Extension at Community Level of Safe Male Circumcision (ANRS 12126 ORANGE FARM 2)
Condition: HIV Infections
Intervention: Procedure: Male Circumcision
8 Completed
Has Results
Raltegravir Intensification in HIV-infected Patients
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: Placebo
9 Terminated Evaluate Tolerability of a Multi-envelope, Prime-boost HIV Vaccine in Healthy Adults
Condition: HIV Infections
Intervention: Biological: EnvDNA, PolyEnv1, EnvPro
10 Completed Early Versus Delayed Routine HIV Testing in Connecticut Jails
Condition: HIV Infections
Intervention: Other: routine HIV testing
11 Completed
Has Results
FEM-PrEP (Truvada®): Study to Assess the Role of Truvada® in Preventing HIV Acquisition in Women
Condition: HIV Infections
Interventions: Drug: Truvada;   Other: Placebo
12 Completed Drug Interaction Study Between Lumefantrine and Lopinavir/Ritonavir
Condition: HIV Infections
Interventions: Drug: Lumefantrine - lopinavir/ritonavir drug interaction;   Drug: Lumefantrine only arm
13 Completed
Has Results
Clinical Trial of CNS-targeted HAART (CIT2)
Condition: HIV Infections
Intervention: Drug: FDA Approved Antiretroviral Therapy (see list below)
14 Completed Second-line Therapy Antiretroviral in Patients Who Failed Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) - Based Regimens
Condition: HIV Infections
Interventions: Drug: LPV/r;   Drug: LPV/r + TDF/FTC or TDF/3TC
15 Completed ROCKET I - Randomized Open Label Switch for Cholesterol Elevation on Kivexa Evaluation Trial
Condition: HIV Infections
Interventions: Drug: Atripla;   Drug: Kivexa plus Sustiva
16 Completed Three Generic Nevirapine-Based Antiretroviral Treatments in Chinese Patients:Multicentric Observation Cohort
Condition: HIV Infections
Interventions: Drug: Zidovudine (AZT)+ Didanosine (ddI)+ Nevirapine (NVP);   Drug: Stavudine (d4T), Lamivudine (3TC), Nevirapine (NVP);   Drug: Zidovudine (AZT), Lamivudine (3TC), Nevirapine (NVP)
17 Completed Cognitive Stimulation Program in AIDS
Condition: HIV Infections
Intervention: Behavioral: Smartbrain
18 Completed
Has Results
PRO 140 by IV Administration in Adults With HIV-1 Infection
Condition: HIV Infections
Interventions: Drug: PRO 140;   Drug: Placebo
19 Completed Pharmacokinetic Study on Raltegravir and Lamotrigine
Condition: HIV Infection
Interventions: Drug: lamotrigine;   Drug: Raltegravir
20 Completed Raltegravir vs. Lopinavir/Ritonavir, Both in Combination With Truvada, in HIV+ Treatment Naive Individuals
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: Lopinavir/Ritonavir

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.